Joel I. Sorosky

Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Robert A. Burger, Michael W. Sill, Bradley J. Monk et al. · Journal of Clinical Oncology · 2007 · 880 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Harry J. Long, Brian N. Bundy, Edward C. Grendys et al. · Journal of Clinical Oncology · 2005 · 557 citations

Medicine, Gynecology, Oncology +13

Social Support, Psychological Distress, and Natural Killer Cell Activity in Ovarian Cancer

Susan K. Lutgendorf, Anil K. Sood, Barrie Anderson et al. · Journal of Clinical Oncology · 2005 · 338 citations · Full text

Medicine, Immunology, Oncology +17

A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

Gregory P. Sutton, Virginia L. Brunetto, Larry C. Kilgore et al. · Gynecologic Oncology · 2000 · 257 citations

Medicine, Gynecology, Oncology +9

Psychosocial factors and interleukin‐6 among women with advanced ovarian cancer

Erin S. Costanzo, Susan K. Lutgendorf, Anil K. Sood et al. · Cancer · 2005 · 216 citations · Full text

Medicine, Gynecology, Oncology +15